Treatment of latent tuberculosis infection: Back to the beginning

被引:4
作者
Blumberg, HM [1 ]
机构
[1] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30303 USA
关键词
D O I
10.1086/425620
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1772 / 1775
页数:4
相关论文
共 35 条
[21]   ISONIAZID-RESISTANT TUBERCULOSIS - A COMMUNITY OUTBREAK AND REPORT OF A RIFAMPIN PROPHYLAXIS FAILURE [J].
LIVENGOOD, JR ;
SIGLER, TG ;
FOSTER, LR ;
BOBST, JG ;
SNIDER, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (19) :2847-2849
[22]   Use of isoniazid for latent tuberculosis infection in a public health clinic [J].
LoBue, PA ;
Moser, KS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (04) :443-447
[23]   Outcomes of contact investigations of infectious tuberculosis patients [J].
Marks, SM ;
Taylor, Z ;
Qualls, NL ;
Shrestha-Kuwahara, RJ ;
Wilce, MA ;
Nguyen, CH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2033-2038
[24]   Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis - Improved completion rates but more hepatotoxicity [J].
McNeill, L ;
Allen, M ;
Estrada, C ;
Cook, P .
CHEST, 2003, 123 (01) :102-106
[25]   Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months [J].
Menzies, D ;
Dion, MJ ;
Rabinovitch, B ;
Mannix, S ;
Brassard, P ;
Schwartzman, K .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) :445-449
[26]   Twice weekly tuberculosis preventive therapy in HIV infection in Zambia [J].
Mwinga, A ;
Hosp, M ;
Godfrey-Faussett, P ;
Quigley, M ;
Mwaba, P ;
Mugala, BN ;
Nyirenda, O ;
Luo, N ;
Pobee, J ;
Elliott, AM ;
McAdam, KPWJ ;
Porter, JDH .
AIDS, 1998, 12 (18) :2447-2457
[27]  
*NCET, 2004, IMP FUND CUTS TB PRO
[28]  
*NCET, 2004, IMP CUTS TB RES NCET
[29]   Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic [J].
Nolan, CM ;
Goldberg, SV ;
Buskin, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11) :1014-1018
[30]   Isoniazid for latent tuberculosis infection - Approaching 40 and reaching its prime [J].
Nolan, CM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (04) :412-413